{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:29:33Z","timestamp":1788172173716,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9H1078335"],"award-info":[{"award-number":["NRF-2018M3A9H1078335"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cca.2021.11.029","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T10:57:56Z","timestamp":1640775476000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency"],"prefix":"10.1016","volume":"526","author":[{"given":"Yunha","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arum","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2021.11.029_b0005","first-page":"345","article-title":"Autosomal recessive inheritance of human mitochondrial carbamyl phosphate synthetase deficiency","volume":"33","author":"McReynolds","year":"1981","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2021.11.029_b0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/humu.21406","article-title":"Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations","volume":"32","author":"H\u00e4berle","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2021.11.029_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","article-title":"Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland","volume":"12","author":"Nettesheim","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1-2","key":"10.1016\/j.cca.2021.11.029_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2021.11.029_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22241","article-title":"Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole exome sequencing","volume":"32","author":"Zhang","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2021.11.029_b0030","doi-asserted-by":"crossref","first-page":"16950","DOI":"10.1038\/srep16950","article-title":"Structure of human carbamoyl phosphate synthetase: deciphering the on\/off switch of human ureagenesis","volume":"5","author":"de Cima","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2021.11.029_b0035","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0021-9258(18)49372-6","article-title":"Carbamyl phosphate synthetase: studies on the mechanism of action","volume":"233","author":"Metzenberg","year":"1958","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2021.11.029_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/A:1005349306311","article-title":"Molecular genetic research into carbamoyl-phosphate synthase I: molecular defects and linkage markers","volume":"21","author":"Summar","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"22","key":"10.1016\/j.cca.2021.11.029_b0045","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2021.11.029_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005374027693","article-title":"Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan","volume":"21","author":"Uchino","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2021.11.029_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2018.04.006","article-title":"Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening","volume":"124","author":"Merritt","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2021.11.029_b0060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2021.11.029_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1442-200X.2009.02831.x","article-title":"Early neonatal onset carbamoyl-phosphate synthase 1 deficiency treated with continuous hemodiafiltration and early living-related liver transplantation","volume":"51","author":"Ishida","year":"2009","journal-title":"Pediatr. Int."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2021.11.029_b0070","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s00431-003-1347-z","article-title":"Long-term outcome of patients with urea cycle disorders and the question of neonatal screening","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cca.2021.11.029_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2014.09.014","article-title":"Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression","volume":"113","author":"Hu","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.cca.2021.11.029_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.spen.2008.05.007","article-title":"Neurologic damage and neurocognitive dysfunction in urea cycle disorders","volume":"15","author":"Enns","year":"2008","journal-title":"Semin. Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.cca.2021.11.029_b0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jimd.12180","article-title":"Inborn errors of enzymes in glutamate metabolism","volume":"43","author":"Rumping","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2021.11.029_b0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuron.2017.07.009","article-title":"Wrapped to adapt: experience-dependent myelination","volume":"95","author":"Mount","year":"2017","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.cca.2021.11.029_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.cca.2021.11.029_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.578922","article-title":"Disturbance of the glutamate-glutamine cycle, secondary to hepatic damage, compromises memory function","volume":"15","author":"Lim\u00f3n","year":"2021","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.cca.2021.11.029_b0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/gim.2014.148","article-title":"Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder","volume":"17","author":"Lee","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2021.11.029_b0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13023-016-0493-0","article-title":"Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001\u20132013","volume":"11","author":"Unsinn","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.cca.2021.11.029_b0115","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.cca.2021.11.029_b0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e3181a27a16","article-title":"Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders","volume":"66","author":"Krivitzky","year":"2009","journal-title":"Pediatr. Res."},{"issue":"12","key":"10.1016\/j.cca.2021.11.029_b0125","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/lt.22407","article-title":"Late-onset carbamoyl phosphate synthetase 1 deficiency in an adult cured by liver transplantation","volume":"17","author":"Bates","year":"2011","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1016\/j.cca.2021.11.029_b0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/humu.21272","article-title":"Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis","volume":"31","author":"Pekkala","year":"2010","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.cca.2021.11.029_b0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10038-007-0122-9","article-title":"Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency","volume":"52","author":"Kurokawa","year":"2007","journal-title":"J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.cca.2021.11.029_b0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s004310100725","article-title":"Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts","volume":"160","author":"Rapp","year":"2001","journal-title":"Eur. J. Pediatr."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2021.11.029_b0145","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.ymgme.2003.08.027","article-title":"The role of liver transplantation in urea cycle disorders","volume":"81","author":"Leonard","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2021.11.029_b0150","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/lt.20587","article-title":"Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University","volume":"11","author":"Morioka","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cca.2021.11.029_b0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF00442137","article-title":"Acute and chronic effects of carbamyl glutamate on blood urea and ammonia","volume":"143","author":"O'Connor","year":"1985","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cca.2021.11.029_b0160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2005.04.059","article-title":"Neonatal hyperammonemia: the N-carbamoyl-L-glutamic acid test","volume":"147","author":"Guffon","year":"2005","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.cca.2021.11.029_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpeds.2014.04.012","article-title":"Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate","volume":"165","author":"Ah Mew","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cca.2021.11.029_b0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2016.12.002","article-title":"Precision medicine in rare disease: mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes","volume":"120","author":"Shi","year":"2017","journal-title":"Mol. Genet. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121004204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121004204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:02:26Z","timestamp":1757862146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121004204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"alternative-id":["S0009898121004204"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.11.029","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}